- Sections
- A - Nécessités courantes de la vie
- A61K - Préparations à usage médical, dentaire ou pour la toilette
- A61K 31/03 - Hydrocarbures halogénés carbocycliques aromatiques
Détention brevets de la classe A61K 31/03
Brevets de cette classe: 340
Historique des publications depuis 10 ans
|
15
|
18
|
26
|
19
|
25
|
17
|
23
|
39
|
40
|
22
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Corcept Therapeutics, Inc. | 345 |
8 |
| The Regents of the University of Michigan | 4733 |
6 |
| The Johns Hopkins University | 5700 |
6 |
| Bio-Pharm Solutions Co., Ltd. | 60 |
6 |
| ChemoCentryx, Inc. | 385 |
6 |
| The Regents of the University of California | 20035 |
4 |
| Neuropro Therapeutics, Inc. | 20 |
4 |
| Orion Corporation | 678 |
4 |
| Lunella Biotech, Inc. | 104 |
4 |
| GABA Therapeutics Inc. | 7 |
4 |
| Iolyx Therapeutics, Inc. | 26 |
4 |
| The General Hospital Corporation | 4759 |
3 |
| President and Fellows of Harvard College | 5992 |
3 |
| Ben-Gurion University of the Negev Research and Development Authority | 203 |
3 |
| BioMendics, LLC | 12 |
3 |
| Gilead Sciences, Inc. | 2042 |
3 |
| New York University | 1751 |
3 |
| Regents of the University of Minnesota | 2698 |
3 |
| Research Institute at Nationwide Children's Hospital | 562 |
3 |
| SK Biopharmaceuticals Co., Ltd. | 262 |
3 |
| Autres propriétaires | 257 |